Maternal psychological reaction to newborn genetic screening for type 1 diabetes

Pediatrics

Volumn 120, Issue 2, 2007, Pages

  Kerruish, Nicola J ^a,b   Campbell Stokes, Priscilla L ^a   Gray, Andrew ^a   Merriman, Tony R ^a   Robertson, Stephen P ^a   Taylor, Barry J ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Diabetes type 1; Genetic predisposition; Newborn screening

Indexed keywords

ADULT; ANXIETY; ARTICLE; DEPRESSION; FEMALE; GENETIC RISK; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HIGH RISK POPULATION; HUMAN; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MATERNAL ATTITUDE; NEWBORN SCREENING; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; SCORING SYSTEM;

ADULT; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; GENETIC SCREENING; HUMANS; INFANT, NEWBORN; LONGITUDINAL STUDIES; MALE; MOTHER-CHILD RELATIONS; MOTHERS; NEONATAL SCREENING; PREGNANCY; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS;

EID: 34547660508     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2006-1381     Document Type: Article

References (71)

1. Human Genetics Commission. Profiling the newborn. 2005. Available at: www.hgc.gov.uk/Client/news_item.asp?NewsId=38. Accessed January 31, 2006
2. Levy HL. Lessons from the past-looking to the future. Newborn screening. Pediatr Ann. 2003;32:505-508
3. Khoury MJ, McCabe LL, McCabe ER. Population screening in the age of genomic medicine. N Engl J Med. 2003;348:50-58
4. Paul D. Contesting consent: the challenge to compulsory neonatal screening for PKU. Perspect Biol Med. 1999;42:207-219
5. Alexander D, van Dyck PC. A vision of the future of newborn screening. Pediatrics. 2006;117(suppl):S350-S354
6. Goldstein DB, Cavalleri GL. Genomics: understanding human diversity. Nature. 2005;437:1241-1242
7. Collins FS, Green ED, Guttmacher AE, Guyer MS. A vision for the future of genomics research. Nature. 2003;422:835-847
8. Evans JP, Skrzynia C, Burke W. The complexities of predictive genetic testing. BMJ. 2001;322:1052-1056
9. Clarke A. The genetic testing of children. Working Party of the Clinical Genetics Society (UK). J Med Genet. 1994;31:785-797
10. American Society of Human Genetics Board of Directors, American College of Medical Genetics Board of Directors. Points to consider: ethical, legal, and psychosocial implications of genetic testing in children and adolescents. Am J Hum Genet. 1995;57:1233-1241
11. Human Genetics Society of Australasia. Predictive testing in children and adolescents. 2003. Available at: hgsa.com.au/images/UserFiles/Attachments/ Predictivetesting(General)APRIL2005. pdf. Accessed May 26, 2007
12. Nelson RM, Botkjin JR, Kodish ED, et al. Ethical issues with genetic testing in pediatrics. Pediatrics. 2001;107:1451-1455
13. Ross LF. Minimizing risks: the ethics of predictive diabetes mellitus screening research in newborns. Arch Pediatr Adolesc Med. 2003;157:89-95
14. al-Jader LN, Goodchild MC, Ryley HC, Harper PS. Attitudes of parents of cystic fibrosis children towards neonatal screening and antenatal diagnosis. Clin Genet. 1990;38:460-465
15. Michie S, Marteau T. Predictive genetic testing in children: the need for psychological research. In: Clarke A, ed. The Genetic Testing of Children. Oxford, United Kingdom: BIOS Scientific Publishers Ltd; 1998:331
16. Green M, Solnit AJ. Reactions to the threatened loss of a child: a vulnerable child syndrome. Pediatric management of the dying child: part III. Pediatrics. 1964;34:58-66
17. Kemper K, Forsyth B, McCarthy P. Persistent perceptions of vulnerability following neonatal jaundice. Am J Dis Child. 1990; 144:238-241
18. Thomasgard M, Metz WP. The vulnerable child revisited: review article. J Dev Behav Pediatr. 1995;16:47-53
19. Leslie LK, Boyce WT. The vulnerable child. Pediatr Rev. 1996; 17:323-326
20. Eurodiab ACE Study Group. Variation and trends in incidence of childhood diabetes in Europe. Lancet. 2000;355:873-876
21. Campbell-Stokes PL, Taylor BJ. Prospective incidence study of diabetes mellitus in New Zealand children aged 0 to 14 years. Diabetologia. 2005;48:643-648
22. Devendra D, Liu E, Eisenbarth GS. Type 1 diabetes: recent developments. BMJ. 2004;328:750-754
23. Vogt RF Jr, Meredith N, Henderson LO, Hannon WH. Newborn screening and type 1 diabetes: historical perspective and current activities at the CDC Division of Laboratory Sciences. Diabetes Technol Ther. 2003;5:1017-1021
24. Buzzetti R, Quattrocchi CC, Nistico L. Dissecting the genetics of type 1 diabetes: relevance for familial clustering and differences in incidence. Diabetes Metab Rev. 1998;14:111-128
25. Todd JA. From genome to aetiology in a multifactorial disease, type 1 diabetes. Bioessays. 1999;21:164-174
26. She JX. Susceptibility to type I diabetes: HLA-DQ and DR revisited. Immunol Today. 1996;17:323-329
27. Greener M. PANDA identifies babies at risk of developing type 1 diabetes. Mol Med Today. 2000;6:3
28. Rewers M, Bugawan TL, Norris JM, et al. Newborn screening for HLA markers associated with IDDM: diabetes autoimmunity study in the young (DAISY). Diabetologia. 1996;39: 807-812
29. Sadeharju K, Hamalainen AM, Knip M, et al. Enterovirus infections as a risk factor for type I diabetes: virus analyses in a dietary intervention trial. Clin Exp Immunol. 2003;132:271-277
30. Berzina L, Shtauvere-Brameus A, Ludvigsson J, Sanjeevi CB. Newborn screening for high-risk human leukocyte antigen markers associated with insulin-dependent diabetes mellitus: the ABIS study. Ann N Y Acad Sci. 2002;958:312-316
31. The Environmental Determinants of Diabetes in the Young (TEDDY). Available at: http://teddy.epi.usf.edu. Accessed December 6, 2005
32. Savelkoul PH, de Bruyn-Geraets DP, van den Berg-Loonen EM. High resolution HLA-DRB1 SSP typing for cadaveric donor transplantation. Tissue Antigens. 1995;45:41-48
33. Redondo MJ, Fain PR, Eisenbarth GS. Genetics of type 1A diabetes. Recent Prog Horm Res. 2001;56:69-89
34. Bleich D, Polak M, Eisenbarth GS, Jackson RA. Decreased risk of type I diabetes in offspring of mothers who acquire diabetes during adrenarchy. Diabetes. 1993;42:1433-1439
35. Dahlquist G, Blom L, Tuvemo T, Nystrom L, Sandstrom A, Wall S. The Swedish childhood diabetes study: results from a nine year case register and a one year case-referent study indicating that type 1 (insulin-dependent) diabetes mellitus is associated with both type 2 (non-insulin-dependent) diabetes mellitus and autoimmune disorders. Diabetologia. 1989;32:2-6
36. Tillil H, Kobberling J. Age-corrected empirical genetic risk estimates for first-degree relatives of IDDM patients. Diabetes. 1987;36:93-99
37. Tuomilehto J, Lounamaa R, Tuomilehto-Wolf E, et al. Epidemiology of childhood diabetes mellitus in Finland-background of a nationwide study of type 1 (insulin-dependent) diabetes mellitus. The Childhood Diabetes in Finland (DiMe) Study Group. Diabetologia. 1992;35:70-76
38. Warram JH, Krolewski AS, Gottlieb MS, Kahn CR. Differences in risk of insulin-dependent diabetes in offspring of diabetic mothers and diabetic fathers. N Engl J Med. 1984;311:149-152
39. TrialNet. Available at: www.diabetestrialnet.org. Accessed April 5, 2006
40. Kerruish NJ, Settle K, Campbell-Stokes P, Taylor BJ. Vulnerable Baby Scale: development and piloting of a questionnaire to measure maternal perceptions of their baby's vulnerability. J Paediatr Child Health. 2005;41:419-423
41. Forsyth BW, Horwitz SM, Leventhal JM, Burger J, Leaf PJ. The child vulnerability scale: an instrument to measure parental perceptions of child vulnerability. J Pediatr Psychol. 1996;21: 89-101
42. Boyce P, Stubbs J, Todd A. The Edinburgh Postnatal Depression Scale: validation for an Australian sample. Aust N Z J Psychiatry. 1993;27:472-476
43. Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry. 1987;150:782-786
44. Cox JL, Chapman G, Murray D, Jones P. Validation of the Edinburgh Postnatal Depression Scale (EPDS) in non-postnatal women. J Affect Disord. 1996;39:185-189
45. Webster ML, Thompson JM, Mitchell EA, Werry JS. Postnatal depression in a community cohort. Aust N Z J Psychiatry. 1994; 28:42-49
46. Spielberger C, Gorsuch R, Lushene R, Vagg P, Jacobs G. STAI Manual for the State Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press; 1970
47. Stuart S, Couser G, Schilder K, O'Hara MW, Gorman L. Postpartum anxiety and depression: onset and comorbidity in a community sample. J Nerv Ment Dis. 1998;186:420-424
48. Intercooled Stata for Windows [computer program]. Release 8.0. College Station, TX: Stata Corporation; 2003
49. O'Hara M, Swain A. Rates and risk of postpartum depression: a meta-analysis. Int Rev Psychiatry. 1996;8:37-54
50. Aktan-Collan K, Haukkala A, Mecklin JP, Uutela A, Kaariainen H. Psychological consequences of predictive genetic testing for hereditary non-polyposis colorectal cancer (HNPCC): a prospective follow-up study. Int J Cancer. 2001;93:608-611
51. Broadstock M, Michie S, Marteau T. Psychological consequences of predictive genetic testing: a systematic review. Eur J Hum Genet. 2000;8:731-738
52. Gritz ER, Peterson SK, Vernon SW, et al. Psychological impact of genetic testing for hereditary nonpolyposis colorectal cancer. J Clin Oncol. 2005;23:1902-1910
53. Power TE, Adams PC. Psychosocial impact of C282Y mutation testing for hemochromatosis. Genet Test. 2001;5:107-110
54. Ritvo P, Irvine J, Robinson G, et al. Psychological adjustment to familial-genetic risk assessment for ovarian cancer: predictors of nonadherence to surveillance recommendations. Gynecol Oncol. 2002;84:72-80
55. Boland C, Thompson NL. Effects of newborn screening of cystic fibrosis on reported maternal behaviour. Arch Dis Child. 1990; 65:1240-1244
56. Green J, Hewison J, Bekker H, Bryant L, Cuckle H. Psychosocial aspects of genetic screening of pregnant women and newborns: a systematic review. Health Technol Assess. 2004;8: 1-109
57. Parsons EP, Clarke AJ, Hood K, Lycett E, Bradley DM. Newborn screening for Duchenne muscular dystrophy: a psychosocial study. Arch Dis Child Fetal Neonatal Ed. 2002;86:F91-F95
58. Tluczek A, Koscik RL, Farrell PM, Rock MJ. Psychosocial risk associated with newborn screening for cystic fibrosis: parents' experience while awaiting the sweat-test appointment. Pediatrics. 2005;115:1692-1703
59. Crockett R, Wright AJ, Uus K, Bamford J, Marteau TM. Maternal anxiety following newborn hearing screening: the moderating role of knowledge. J Med Screen. 2006;13:20-25
60. Eberhard-Gran M, Eskild A, Tambs K, Opjordsmoen S, Samuelsen SO. Review of validation studies of the Edinburgh Postnatal Depression Scale. Acta Psychiatr Scand. 2001;104:243-249
61. Bennett Johnson S, Baughcum AE, Carmichael SK, She JX, Schatz DA. Maternal anxiety associated with newborn genetic screening for type 1 diabetes. Diabetes Care. 2004;27:392-397
62. Hood KK, Bennett Johnson S, Carmichael SK, Laffel LM, She JX, Schatz DA. Depressive symptoms in mothers of infants identified as genetically at risk for type 1 diabetes. Diabetes Care. 2005;28:1898-1903
63. Yu MS, Norris JM, Mitchell CM, et al. Impact on maternal parenting stress of receipt of genetic information regarding risk of diabetes in newborn infants. Am J Med Genet. 1999;86: 219-226
64. Baroni MA, Anderson YE, Mischler E. Cystic fibrosis newborn screening: impact of early screening results on parenting stress. Pediatr Nurs. 1997;23:143-151
65. Gurian EA, Kinnamon DD, Henry JJ, Waisbren SE. Expanded newborn screening for biochemical disorders: the effect of a false-positive result. Pediatrics. 2006;117:1915-1921
66. Abidin R, ed. Parenting Stress Index: Professional Manual. 3rd ed. Odessa, FL: Psychological Assessment Resources; 1995
67. Thomas KA, Renaud MT, Depaul D. Use of the parenting stress index in mothers of preterm infants. Adv Neonatal Care. 2004; 4:33-41
68. McNeil TF, Thelin T, Aspegren-Jansson E, Sveger T. Identifying children at high somatic risk: possible effects on the parents' views of the child's health and parents' relationship to the pediatric health services. Acta Psychiatr Scand. 1985;72:491-497
69. Barker JM, Goehrig SH, Barriga K, et al. Clinical characteristics of children diagnosed with type 1 diabetes through intensive screening and follow-up. Diabetes Care. 2004;27:1399-1404
70. Eiser JR. Communication and interpretation of risk. Br Med Bull. 1998;54:779-790
71. Catz DS, Green NS, Tobin JN, et al. Attitudes about genetics in underserved, culturally diverse populations. Community Genet. 2005;8:161-172